| - GRCh37:
- Chr16:2096293
- GRCh38:
- Chr16:2046292
| NTHL1 | D64Y | Familial adenomatous polyposis 3 | Uncertain significance (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:2096298
- GRCh38:
- Chr16:2046297
| NTHL1 | A3fs, G62fs | Familial adenomatous polyposis 3 | Pathogenic (Jan 19, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:2096284
- GRCh38:
- Chr16:2046283
| NTHL1 | K67*, R7S | Familial adenomatous polyposis 3 | Pathogenic (Jan 19, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:2093639
- GRCh38:
- Chr16:2043638
| NTHL1 | A95E, A148E, A205E | Familial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome
| Uncertain significance (Mar 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2090180
- GRCh38:
- Chr16:2040179
| NTHL1 | K139*, K192*, K249* | Familial adenomatous polyposis 3 | Likely pathogenic (May 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:2090189
- GRCh38:
- Chr16:2040188
| NTHL1 | K136*, K189*, K246* | Familial adenomatous polyposis 3, not provided | Pathogenic (Mar 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2097731
- GRCh38:
- Chr16:2047730
| NTHL1 | R32W | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Oct 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2096242
- GRCh38:
- Chr16:2046241
| NTHL1 | P81A | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Nov 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2093592
- GRCh38:
- Chr16:2043591
| NTHL1 | A111T, A164T, A221T | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome | Uncertain significance (May 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2096376
- GRCh38:
- Chr16:2046375
| NTHL1 | | Familial adenomatous polyposis 3, not provided | Uncertain significance (Jan 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2093580
- GRCh38:
- Chr16:2043579
| NTHL1 | V115M, V168M, V225M | not provided, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3
| Uncertain significance (Apr 27, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2096134
- GRCh38:
- Chr16:2046133
| NTHL1 | P117T | not specified, not provided, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 | Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2096377
- GRCh38:
- Chr16:2046376
| NTHL1 | | Familial adenomatous polyposis 3, not specified, not provided
| Benign/Likely benign (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2097701
- GRCh38:
- Chr16:2047700
| NTHL1 | | Familial adenomatous polyposis 3, not provided | Likely benign (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2093728
- GRCh38:
- Chr16:2043727
| NTHL1 | | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Pathogenic/Likely pathogenic (Feb 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2097794
- GRCh38:
- Chr16:2047793
| NTHL1 | R11W | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Feb 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2094711
- GRCh38:
- Chr16:2044710
| NTHL1 | R149W, R39W | not provided, Hereditary cancer-predisposing syndrome | Uncertain significance (May 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2097805
- GRCh38:
- Chr16:2047804
| NTHL1 | R7T | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Feb 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2097779
- GRCh38:
- Chr16:2047778
| NTHL1 | G16R | not provided, Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome
| Uncertain significance (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2093676
- GRCh38:
- Chr16:2043675
| NTHL1 | G83S, G193S, G136S | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided, not specified | Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2094798
- GRCh38:
- Chr16:2044797
| NTHL1 | R10G, R120G | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Feb 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2090179
- GRCh38:
- Chr16:2040178
| NTHL1 | K192R, K139R, K249R | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided, not specified | Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2090162
- GRCh38:
- Chr16:2040161
| NTHL1 | R198C, R255C, R145C | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2097709
- GRCh38:
- Chr16:2047708
| NTHL1 | | not provided, Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome
| Pathogenic/Likely pathogenic (Jul 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2090156
- GRCh38:
- Chr16:2040155
| NTHL1 | A200T, A147T, A257T | Familial adenomatous polyposis 3, not specified, Hereditary cancer-predisposing syndrome, not provided | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:2097720
- GRCh38:
- Chr16:2047719
| NTHL1 | E35D | Familial adenomatous polyposis 3, not provided | Uncertain significance (May 31, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2094701
- GRCh38:
- Chr16:2044700
| NTHL1 | T42K, T152K | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2093633
- GRCh38:
- Chr16:2043632
| NTHL1 | P150L, P207L, P97L | Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Aug 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2093573
- GRCh38:
- Chr16:2043572
| NTHL1 | G227D, G170D, G117D | not provided, not specified, Hereditary cancer-predisposing syndrome
| Uncertain significance (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2097818
- GRCh38:
- Chr16:2047817
| NTHL1 | A3S | Familial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2096334
- GRCh38:
- Chr16:2046333
| NTHL1 | P50L | Hereditary cancer-predisposing syndrome, not provided | Uncertain significance (Feb 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2090143
- GRCh38:
- Chr16:2040142
| NTHL1 | W151*, W204*, W261* | not provided, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3
| Likely pathogenic (Jun 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2090005
- GRCh38:
- Chr16:2040004
| NTHL1 | Q279*, Q222*, Q169* | Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3, not provided
| Pathogenic/Likely pathogenic (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2090008
- GRCh38:
- Chr16:2040007
| NTHL1 | G278S, G168S, G221S | not provided, Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome
| Uncertain significance (Mar 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2094653
- GRCh38:
- Chr16:2044652
| NTHL1 | I168T, I58T | Hereditary cancer-predisposing syndrome, not specified, Familial adenomatous polyposis 3, not provided | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:2096271-2096272
- GRCh38:
- Chr16:2046270-2046271
| NTHL1 | A71fs | not provided, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3
| Pathogenic/Likely pathogenic (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2096209
- GRCh38:
- Chr16:2046208
| NTHL1 | R92C | Familial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome, not specified | Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:2093567
- GRCh38:
- Chr16:2043566
| NTHL1 | | Familial adenomatous polyposis 3, not provided | Pathogenic/Likely pathogenic (Feb 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:2096239
- GRCh38:
- Chr16:2046238
| NTHL1 | Q82* | Familial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Aug 15, 2023) | criteria provided, conflicting interpretations |